DBeQ, >=98% (HPLC)

DBeQ, >=98% (HPLC)

Application

HeLa cells were treated with DBeQ and the effects on in vivo ubiquitination and protein dislocation were studied by live cell imaging.

Biochem/physiol Actions

DBeQ is a potent and specific inhibitor of ATPase p97, an integral component of the ubiquitin-fusion degradation (UFD) pathway. DBeQ inhibits the degradation of ubiquitinated proteins, the endoplasmic reticulum-associated degradation pathway, and autophagosome maturation. The compound also potently inhibits cellular proliferation and induces caspase 3/7 activity and apoptosis.

Packaging

5, 25 mg in glass bottle

No detailed specifications are available for this product.

There are no downloads for this product.

Code Description Colour Quality Level InChI key InChI Manufacturer Solubility Form Assay Price Quantity
3573987 DBeQ, >=98% (HPLC) white to beige 100 QAIMUUJJAJBPCL-UHFFFAOYSA-N 1S/C22H20N4/c1-3-9-17(10-4-1)15-23-21-19-13-7-8-14-20(19)25-22(26-21)24-16-18-11-5-2-6-12-18/h1-14H,15-16H2,(H2,23,24,25,26) SIGMA-ALDRICH DMSO: ≥20 mg/mL powder ≥98% (HPLC)
£520.93 (exc VAT) per 25MG
-
+
3573988 DBeQ, >=98% (HPLC) white to beige 100 QAIMUUJJAJBPCL-UHFFFAOYSA-N 1S/C22H20N4/c1-3-9-17(10-4-1)15-23-21-19-13-7-8-14-20(19)25-22(26-21)24-16-18-11-5-2-6-12-18/h1-14H,15-16H2,(H2,23,24,25,26) SIGMA-ALDRICH DMSO: ≥20 mg/mL powder ≥98% (HPLC)
£150.43 (exc VAT) per 5MG
-
+